HomeCompareNHOXF vs MRK

NHOXF vs MRK: Dividend Comparison 2026

NHOXF yields 2.84% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $32.8K in total portfolio value
10 years
NHOXF
NHOXF
● Live price
2.84%
Share price
$14.50
Annual div
$0.41
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.0K
Annual income
$341.65
Full NHOXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NHOXF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHOXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHOXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHOXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHOXF
Annual income on $10K today (after 15% tax)
$241.75/yr
After 10yr DRIP, annual income (after tax)
$290.40/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,038.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHOXF + MRK for your $10,000?

NHOXF: 50%MRK: 50%
100% MRK50/50100% NHOXF
Portfolio after 10yr
$40.4K
Annual income
$5,069.90/yr
Blended yield
12.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NHOXF
No analyst data
Altman Z
2.0
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHOXF buys
0
MRK buys
0
No recent congressional trades found for NHOXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHOXFMRK
Forward yield2.84%2.76%
Annual dividend / share$0.41$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$24.0K$56.8K
Annual income after 10y$341.65$9,798.13
Total dividends collected$3.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NHOXF vs MRK ($10,000, DRIP)

YearNHOXF PortfolioNHOXF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,984$284.41$11,206$366.19$222.00MRK
2$12,045$291.97$12,650$502.35$605.00MRK
3$13,188$299.23$14,407$694.19$1.2KMRK
4$14,417$306.17$16,585$967.82$2.2KMRK
5$15,739$312.82$19,342$1,363.89$3.6KMRK
6$17,160$319.16$22,913$1,947.19$5.8KMRK
7$18,686$325.21$27,662$2,823.89$9.0KMRK
8$20,325$330.97$34,159$4,173.35$13.8KMRK
9$22,085$336.45$43,337$6,308.80$21.3KMRK
10$23,972$341.65$56,776$9,798.13$32.8KMRK

NHOXF vs MRK: Complete Analysis 2026

NHOXFStock

Nederman Holding AB (publ) operates as an environmental technology company in Sweden and internationally. The company operates through four segments: Nederman Extraction & Filtration Technology; Nederman Duct & Filter Technology; Nederman Process Technology; and Nederman Monitoring & Control Technology. It offers industrial air filtration products for heavy process industries, including metal fabrication, power generation, mineral processing, chemical, and other industries, as well as for fiber-based production, process industry operations, and auto industry aftermarket sectors. The company also provides air filtration products, such as gas turbine inlet air filtration systems, and filters and related media products for the power generation and textile industries under the Nederman Pneumafil brand. In addition, it offers metal chip processing and ash handling systems to metal machining plants, metal recyclers, solid fuel-fired power plants, and others under the Nederman National Conveyors brand name; and designs and engineers components and systems, as well as provide manufacturing, assembling, installation, and after-sales services. Further, the company offers technologies for evaporation, drying, and filtration of liquids; and extrusion, spheronization, feeding, and pelleting in the chemical industry under the LCI brand name. Additionally, it supplies gas and dust analyzers based on tuneable diode laser absorption spectroscopy; and provides particulate monitors and intelligent controls for filtration systems and related material flow processes. The company also develops, manufactures, and markets solutions for monitoring industrial emissions and portable instruments. It sells its products through its own sales organization, agents, and resellers. The company was founded in 1944 and is headquartered in Helsingborg, Sweden.

Full NHOXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NHOXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHOXF vs SCHDNHOXF vs JEPINHOXF vs ONHOXF vs KONHOXF vs MAINNHOXF vs JNJNHOXF vs ABBVNHOXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.